Windlas Biotech Limited (WINDLAS) — Financial Results | 24 July 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

About Windlas Biotech Limited (WINDLAS)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,645.02 Cr P/E: 26.4

View full WINDLAS stock details →

📡 Get AI alerts when WINDLAS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track WINDLAS — Free

📊 More WINDLAS filings

See all WINDLAS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when WINDLAS files new disclosures

Track WINDLAS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track WINDLAS — Free

Free account · 2 AI queries/day